Physician profile
Judith Birungi
NPI 1609183953
$16,160.47
in general payments reported to CMS, 2019-2025
7 companies · $1,605 in 2025
The $1,605 reported for 2025 was more than what 79% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.63 · 2020: $16.08 · 2021: $26.09 · 2022: $8,223 · 2023: $4,540 · 2024: $1,722 · 2025: $1,605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,729 · Education: $3,000 · Food and Beverage: $1,122 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,729.09 |
| Education | $3,000.00 |
| Food and Beverage | $1,121.57 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,727.98 | 2022-2025 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $1,244.82 | 2024-2025 | Phasix Mesh |
| Innovation Technologies INC | $68.43 | 2022-2023 | Irrisept |
| Merck Sharp & Dohme LLC | $48.44 | 2023-2025 | Bridion |
| Melinta Therapeutics, LLC | $30.52 | 2020-2021 | |
| Ethicon US, LLC | $28.63 | 2019 | |
| Smith+Nephew, INC. | $11.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Birungi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.